2nd Quarter - Report

THE JACKSON LABORATORY for THE JACKSON LABORATORY

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues pertaining to funding for the National Institutes of Health and National Science Foundation.

LobbyistCovered position, as disclosed
JILL HOMER STEWART New Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Issues related to animal use in biomedical research.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues pertaining to biomedical research.

LobbyistCovered position, as disclosed
JILL HOMER STEWART New Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Agriculture AGR

Issues related to the Farm Bill, H.R. 2.

LobbyistCovered position, as disclosed
JILL HOMER STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2 (115th)

Health Issues HCR

Issues pertaining to NIH funding and regulation Issues relating to disease research Opioid addiction S. 2076, the BOLD Infrastructure for Alzheimer's Act

LobbyistCovered position, as disclosed
JILL HOMER STEWART New Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2076 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.